Table 3.
Comparison of the 69 patients with and 119 patients without granulomas
| Granulomas (%) (n = 69) | No granulomas (%) (n = 119) | |
| Age (y) | ||
| Mean (SD) | 34.2 (20.6) | 37.7 (19.9) |
| Median (range) | 25.8 (5.9–85.9) | 30.3 (8.7–82.1) |
| Sex (F/M) | 38/31 | 60/59 |
| Follow up duration (months) | ||
| Mean (SD) | 57.8 (27.2) | 55.4 (27.6) |
| Median (range) | 66 (0.1–88) | 67 (0–93) |
| Anoperineal involvement | ||
| Initial | 9 (20)* | 9 (6) |
| At last follow up | 20 (29)* | 13 (13) |
| Extraintestinal manifestations | ||
| Initial | 5 (11) | 15 (11) |
| At last follow up | 19 (28) | 32 (27) |
| Glucocorticoid therapy | 48 (70)*** | 47 (40) |
| Immunosuppressant agents | 17 (25) | 16 (13) |
| Patients with surgery for CD | 25 (36)*** | 16 (13) |
| Patients with surgical bowel resection | 18 (28)*** | 10 (8) |
| Patients with anoperineal surgery | 8 (12) | 6 (5) |
| No of anoperineal surgery | 14 (20)*** | 7 (6) |
| Hospitalisation for CD flare up | 29 (42)* | 31/119 (26) |
| Death | 4 (5.8) | 3 (2.5) |
CD, Crohn’s disease.
*p<0.05; ***p<0.001.